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Abstract
 Introduction: Progesterone-treated females eat more food, but the mechanism underlying this effect is not well understood. The aim of 
the study was to analyse the effect of progesterone on neuropeptide genes expression in rat hypothalamus. 
Material and methods: Experiments were carried out on female and male Wistar rats. Animals were treated with progesterone (100 mg 
per rat) for 28 days. NPY and CART mRNA levels in hypothalamus were quantified by real-time PCR. The serum progesterone concentra-
tion was determined by radioimmunoassay.
Results: Progesterone administration to females caused an increase in food intake, body mass, and white adipose tissue mass. Elevated 
circulating progesterone concentration up-regulated NPY and down-regulated CART genes expression in hypothalamus of females. In 
males, elevated blood progesterone concentration had no effect on food intake, body and fat mass and on the neuropeptide genes expres-
sion in hypothalamus. Moreover, administration of progesterone in females resulted in decrease of PR mRNA level in hypothalamus. No 
effect of progesterone administration on PR mRNA level in hypothalamus of males was found.
Conclusions: The changes in neuropeptide genes expression in hypothalamus may lead to stimulation of appetite and might explain 
the observed increase in food intake, body and adipose tissue mass in progesterone-treated females. (Endokrynol Pol 2014; 65 (1): 46–53)
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Streszczenie
Wstęp: Podanie progesteronu samicom szczura prowadzi do wzrostu ilości spożywanego przez nie pokarmu, jednak mechanizmy 
odpowiedzialne za ten efekt nie są do końca znane. Celem tej pracy było sprawdzenie, czy obserwowane pod wpływem progesteronu 
zmiany w ilości spożywanego pokarmu przez szczury mogą być związane ze zmianami ekspresji genów neuropeptydów w podwzgórzu. 
Materiał i metody: Doświadczenie zostało przeprowadzone na samicach i samcach szczura rasy Wistar. Po 28 dniach po podaniu proge-
steronu (100 mg/szczura) pobrano podwzgórza i zmierzono poziom mRNA NPY i CART w oparciu o metodę PCR w czasie rzeczywistym. 
Stężenie progesteronu w surowicy krwi badanych zwierząt oznaczono metodą radioimmunologiczną.
Wyniki: Podanie progesteronu prowadzi do wzrostu masy ciała, tkanki tłuszczowej i ilości spożywanego pokarmu u samic szczura. 
Zmianom tym towarzyszy wzrost ekspresji genu NPY i obniżenie ekspresji genu CART w podwzgórzu. U samców podanie progesteronu 
nie ma wpływu na masę ciała, masę tkanki tłuszczowej i ilość spożywanego pokarmu oraz ekspresję genów neuropeptydów w podwzgó-
rzu. Ponadto wykazano, że podanie progesteronu samicom szczura prowadzi do obniżenia ekspresji genu receptora progesteronowego 
w podwzgórzu. Zmian takich nie zaobserwowano u samców. 
Wnioski: Zmiany ekspresji genów neuropeptydów w podwzgórzu samic szczura, którym podano progesteron, mogą prowadzić do sty-
mulacji apetytu, co w konsekwencji wpływa na wzrost ilości spożywanego pokarmu, zwiększenie masy ciała i masy tkanki tłuszczowej. 
(Endokrynol Pol 2014; 65 (1): 46–53)
Słowa kluczowe: progesteron; transkrypt regulowany przez kokainę i amfetaminę (CART); neuropeptyd Y (NPY); receptor progesteronowy (PR)
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Introduction
Progesterone regulates various functions in the body 
related not only to reproduction or ovulation [1]. Some 
data suggests that progesterone may affect carbohy-
drates and lipids metabolism, organism growth, body 
composition and food intake [2, 3]. Studies on rodents 
have demonstrated that progesterone treatment in-
creases body weight and adipose tissue mass by regu-
lation of the expression of specific genes [4]. It is well 
known that in pregnancy (upon high concentration of 
progesterone in blood) the most important regulatory 
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process is the increase in appetite and food intake. 
It has also been observed that progesterone-treated 
animals eat more food [2, 5, 6], but the mechanism of 
progesterone action on food intake is still elusive. Un-
der physiological conditions, across the ovarian cycle, 
female rats eat up to 25% less during the night of ovula-
tion and oestrus (the day after progesterone release). 
However, this is the effect of oestradiol not progester-
one. Ovariectomy eliminates cycle and increases daily 
food intake. Oestradiol treatment reverses these effects, 
but progesterone treatment has no such effect [7]. Only 
a pharmacological dose of progesterone can reverse 
the inhibitory effect of oestradiol on eating in rats [8]. 
In women, enhancement of eating during luteal phase 
has been attributed to increased plasma progesterone, 
but there is little support for this suggestion. Moreover, 
some studies indicate that a pharmacological dose of 
progesterone had no effect on eating in women [9]. It is 
worth noting that a synthetic progesterone derivative 
(17a-OH-progesterone derivative) — megestrol acetate 
— is being used to stimulate appetite and to induce 
weight gain in patients with cancer or AIDS, as well as 
in cachectic elderly subjects [10, 11].
It has been observed that progesterone-treated 
animals eat more food, but the mechanisms underlying 
these effects are not well understood. It is commonly 
known that hypothalamic orexigenic (like NPY) and 
anorexigenic (i.e. CART) neuropeptides play an impor-
tant role in the regulation of appetite and body weight 
homeostasis. Under physiological conditions, various 
factors are involved in the regulation of neuropeptide 
genes expression [12, 13]. Moreover, some studies have 
indicated that food restriction, fasting or refeeding affect 
neuropeptide genes expression in hypothalamus [14–16]. 
The influence of progesterone on neuropeptide 
genes expression is not clearly defined. It has been 
shown that progesterone penetrates to different regions 
of the brain, including the hypothalamus [17]. The pres-
ence of progesterone receptor (PR) in hypothalamus 
was also proven [18]. Progesterone has been reported 
to increase NPY content of the hypothalamus in oestro-
gen-primed [19] and oestrogen-primed ovariectomised 
rats [20, 21]. The expression of neuropeptide genes in 
hypothalamus upon high level of progesterone in rats 
is different. Some data shows a significant increase of 
NPY and AgRP mRNA levels, and decrease of POMC 
mRNA level in the arcuate nucleus of pregnant rats [6]. 
In pseudopregnant rats, despite hyperphagia and the 
high level of progesterone, hypothalamic levels of the 
same neuropeptides were found unchanged [6]. 
We have recently shown that progesterone influ-
ences metabolic and endocrine functions of white 
adipose tissue in female rats by regulating some genes 
expression [4, 5]. We observed that progesterone-
treated females, in contrast to males, eat more food 
than controls.  
Based on these observations, and data from the 
literature, we hypothesised that progesterone may 
influence the food intake by regulation of neuropep-
tide genes expression in hypothalamus. The aim of 
this study was to analyse the effect of progesterone on 
NPY and CART genes expression in rat hypothalamus.
Material and methods
Animals and treatment
Ten-week-old female and male Wistar rats, initially 
weighing approximately 200 g and 260 g, respectively, 
were used. The rats were assigned to four groups: control 
females (n = 10), females treated with progesterone (n 
= 10), control males (n = 10) and males treated with pro-
gesterone (n = 10). Under general anaesthesia induced 
by intraperitoneal injection of ketamine (60 mg/kg) 
and xylasine (6 mg/kg), a pharmacological dose (100 mg 
per rat) of progesterone (Sigma-Aldrich, St. Louis, MO, 
USA) was implanted subcutaneously in the lower abdo-
men. Control animals underwent an identical sham-
operation. Males and females were housed in individual 
wire-mesh cages, in the same room at 22°C, under 
a light:dark 12h:12h cycle with lights on at 7:00 a.m. 
The animals were allowed free access to tap water and 
food (the commercial diet composition was described in 
[22]). The amount of consumed food was measured ev-
ery other day. The animals were killed by decapitation 
28 days after the progesterone implantation. Hypo-
thalamus (taken as a whole) was collected (as described 
in [23]), rapidly frozen in liquid nitrogen and stored at 
–80°C for subsequent analyses. Blood was collected from 
the neck artery, centrifuged, and the separated serum 
was stored at –80°C until progesterone concentration 
was measured. All procedures involving the animals 
were conducted in agreement with our institutional 
guidelines for the care and use of laboratory animals.
Determination of serum  
progesterone concentration 
Serum progesterone concentration was measured 
by radioimmunoassay using a commercial immunoas-
say kit, according to the manufacturer’s instructions 
(Institute of Atomic Energy POLATOM, Radioisotope 
Centre, Poland).
RNA isolation
Total cellular RNA was extracted from frozen tissue 
by a guanidinium isothiocyanate/phenol/chloroform 
method [24]. The RNA concentration was determined 
from the absorbance at 260 nm. All samples had 260/280 
nm absorbance ratio of approximately 2.0.
48
PR
A
C
E 
O
RY
G
IN
A
LN
E
Progesterone and neuropeptide genes expression  Ewa Stelmańska, Elżbieta Sucajtys-Szulc
cDNA synthesis
First strand cDNA was synthesised from 4 μg of total 
RNA (RevertAidTM First Strand cDNA Synthesis Kit 
— Fermentas UAB, Lithuania). Prior to amplification of 
cDNA, each RNA sample was treated with RNase-free 
DNase I (Fermentas UAB, Lithuania) at 37°C for 30 min.
Determination of neuropeptides and progesterone 
receptor mRNA levels by real-time PCR
NPY, CART and PR mRNA levels were quantified by 
real-time PCR using Chromo4 Real Time Detection 
System (Bio-Rad Laboratories, Inc, Hercules, CA, 
USA). The primers were designed with Sequence 
Analysis software package (Informagen, Newington, 
USA) from gene sequence obtained from Ensembl 
Genome Browser (www.ensembl.org). The fol-
lowing oligonucleotide primers pairs were used: 
5’-TAGGTAACAAACGAATGGGG-3’ (sense) and 
5’-AGGATGAGTGAGATGTGGG-3’(antisense) for 
NPY; 5’-CTCAAGAGTAAACGCATTCC-3’(sense) and 
5’-ACAAGCACTTCAAGAGGAAA-3’ (antisense) for 
CART; 5’-TCAACCAACTAGGCGAGAGG-3’ (sense) 
and 5’- ACACCATCAGGCTCATCCA-3’(antisense) 
for progesterone receptor; 5’-TGTCACCAACTGAC-
GATA-3’ (sense) and 5’-GGGGTGTTGAAGGTCTCAAA-
3’(antisense) for b-actin; 5’-CTGAGCACTGGGGAGA-
AAGGA-3’ and 5’-GAAGTCACCACCACTGCACA-3’ 
for cyclophilin-A. Real-time PCR amplification was 
performed in a 20 μl volume using iQ SYBR Green Su-
permix (Bio-Rad Laboratories, Hercules, CA, USA). Each 
reaction contained cDNA and 0.3 μM of each primer. 
Samples were incubated for an initial denaturation and 
polymerase activation at 95°C for 5 min followed by 
35 PCR cycles of amplification (92°C for 20 s, 57°C for 
20 s, and 72°C for 40 s). Control reactions, with omission 
of the RT step or with no template cDNA added, were 
performed with each assay. All samples were run in 
triplicate. To compensate for variations in the amount 
of added RNA, and for the efficiency of the reverse 
transcription, b-actin mRNA was quantified in cor-
responding samples and the results were normalised 
to these values. It should be noted that similar results 
using b-actin and cyclophilin-A as housekeeping genes 
were found (not shown). Relative quantities of tran-
scripts were calculated using the 2-DDCT formula [25]. The 
results are expressed in arbitrary units, with one unit 
being the mean mRNA level determined in the control 
group. Amplification of specific transcripts was further 
confirmed by obtaining the melting curve profiles and 
subjecting the amplification products to agarose gel 
electrophoresis.
Statistics
The statistical significance of differences between the 
groups was assessed by a one-way analysis of variance 
(ANOVA) and Tukey’s post-hoc test used for further 
determination of significance of differences. Sigma 
Stat software (Sigma Stat Inc.) was used. Differences 
between the groups were considered significant when 
p < 0.05. All data is presented as means of values (n = 10) 
± standard error of mean (± SEM).
Database Sequence Analysis
The TRANSFAC database (BIOBASE, Beverly, MA, USA) 
was searched using AliBaba 2.1 (BIOBASE) for putative 
PR binding sites on the 5’ flanking sequence (2,000 bp 
upstream and 300 bp downstream from the ATG start 
codon) of the NPY and CART genes. 
Results
Administration of progesterone in females resulted 
in an approximately 2.5-fold increase of serum pro-
gesterone concentration (Table I). As expected, food 
intake was increased in treated females and remained 
elevated for most of the treatment period (Fig. 1A). Sta-
tistically significant differences in food intake between 
control and progesterone treated animals were found 
from the eighth day of the treatment. Food intake by 
progesterone-treated and control males was essentially 
similar (Fig. 1B). At the end of the experiment, the gain 
of body weight in treated females was about 18 g larger 
than in control females (Fig. 2). No significant changes 
in the body weight gain of males (despite several-fold 
increase of serum progesterone concentration [Table I]) 
were found (Fig. 2). The mass of adipose tissue (the 
sum of the inguinal, retroperitoneal and parame-
trial WAT) of rats treated with progesterone, increased 
substantially only in females (Fig. 3). No effect of pro-
gesterone administration on WAT mass in males was 
Table I. Serum progesterone concentration in control and progesterone-treated rats (ng/mL). Data is presented as mean ± SEM; 
number of animals per group (n) = 10
Tabela I. Stężenie progesteronu (ng/ml) w surowicy krwi szczurów kontrolnych i otrzymujących progesteron. Wyniki 
przedstawiają średnią ± SEM; liczba zwierząt w grupie (n) = 10
Gender Control Progesterone-treated Fold change Statistical significance
Females 31.3 ± 6.7 76.8 ± 8.4 2.5 p < 0.01
Males 1.8 ± 0.5 29.2 ± 7.3 16 p < 0.01
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found (Fig. 3). In order to check whether the increase 
of food consumption in treated females is associated 
with changes in gene expression of orexigenic and 
anorexigenic neuropeptides, we measured NPY and 
CART mRNA levels in hypothalamus. Figure 4 shows 
that an elevated circulating progesterone concentra-
tion was associated with an approximately two-fold 
increase of NPY mRNA level in hypothalamus of fe-
males. The increase in orexigenic neuropeptide mRNA 
level by progesterone was associated with a significant 
decrease of anorexigenic neuropeptide mRNA level in 
hypothalamus. Figure 5 shows that CART mRNA level 
was approximately three-fold lower in hypothalamus 
of treated females than in control females. Despite the 
several-fold increase of circulating progesterone con-
centration in progesterone-treated males, no significant 
changes in NPY and CART mRNA levels were found 
in hypothalamus of males (Figs. 4 and 5). It is worth 
noting that the serum concentration of progesterone 
in progesterone-treated males reached the similar 
value observed in non-treated control females (Table I). 
Collectively, these results indicate that progesterone 
administration caused an increase in food consump-
tion of females, associated with an increase of NPY, 
and a decrease of CART mRNA levels in hypotha-
lamus.
We also examined the effect of progesterone’s 
administration on the PR gene expression in hypo-
thalamus of females and males. As shown in Figure 6, 
administration of progesterone in females resulted in 
about a four-fold decrease of PR mRNA level in hypo-
thalamus. No effect of progesterone administration on 
PR mRNA level in hypothalamus of males has been 
found (Fig. 6). 
Figure 1. Daily food intake by control and progesterone-treated females (A) and males (B). Each point represents the mean ± SEM of 
ten animals. *p < 0.05 control female rats versus progesterone-treated female rats. (D) control rats (females or males respectively); () 
progesterone-treated females; () progesterone-treated males
Rycina 1. Ilość spożywanego pokarmu w ciągu jednego dnia przez samice  (A) i samce (B) szczurów kontrolnych i szczurów otrzymujących 
progesteron. Każdy punkt przedstawia średnią ± SEM (n = 10). *p < 0,05 samice kontrolne w porównaniu do samic badanych. 
(D) szczury kontrolne (samice lub samce); () samice, którym podano progesteron; () samce, którym podano progesteron
Figure 2. The body weight gain of control (C) and progesterone-treated rats (P). Data is presented as mean ± SEM (n = 10). *p < 0.01 
control female rats versus progesterone-treated female rats
Rycina 2. Przyrost masy ciała szczurów kontrolnych (C) i szczurów, którym podano progesteron (P). Wyniki przedstawiają średnią ± SEM 
(n = 10). *p < 0,01 samice kontrolne w porównaniu z samicami badanymi (P)
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Figure 3. White adipose tissue mass of control (C) and progesterone-treated (P) rats. Data is presented as mean ± SEM (n = 10). 
*p < 0.01 control female rats versus progesterone-treated female rats
Rycina 3. Masa białej tkanki tłuszczowej szczurów kontrolnych (C) i szczurów otrzymujących progesteron (P). Wyniki przedstawiają 
średnią ± SEM (n = 10). *p < 0,01 samice kontrolne w porównaniu z samicami badanymi (P)
Figure 4. NPY mRNA level in hypothalamus of control (C) and progesterone-treated (P) rats. Data is presented as mean ± SEM 
(n = 10). *p < 0.05 control female rats versus progesterone-treated female rats
Rycina 4. Poziom mRNA neuropeptydu Y w podwzgórzu szczurów kontrolnych (C) i szczurów, którym podano progesteron (P). Wyniki 
przedstawiają średnią ± SEM (n = 10). *p < 0,05 samice kontrolne w porównaniu z samicami badanymi (P)
Figure 5. CART mRNA level in hypothalamus of control (C) and progesterone-treated (P) rats. Data is presented as mean ± SEM 
(n = 10). *p < 0.01 control female rats versus progesterone-treated female rats
Rycina 5. Poziom mRNA CART w podwzgórzu szczurów kontrolnych (C) i szczurów, którym podano progesteron (P). Wyniki 
przedstawiają średnią ± SEM (n = 10). *p < 0,01 samice kontrolne w porównaniu z samicami badanymi (P)
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Figure 6. PR mRNA level in hypothalamus of control (C) and progesterone-treated (P) rats. Data is presented as mean ± SEM 
(n = 10). *p < 0.01 control female rats versus progesterone-treated female rats
Rycina 6. Poziom mRNA receptora progesteronu w podwzgórzu szczurów kontrolnych (C) i szczurów, którym podano progesteron (P). 
Wyniki przedstawiają średnią ± SEM (n = 10). *p < 0,01 samice kontrolne w porównaniu z samicami badanymi (P)
Discussion 
We examined the effect of progesterone on NPY and 
CART mRNA levels in hypothalamus, food intake, body 
weight and adiposity. The changes in the parameters 
were observed only in females. These animals, after 
hormone treatment, showed a higher increase in body 
weight and adipose tissue mass. Our recently published 
results indicate that the increase of white adipose tissue 
mass is associated with hypertrophy of inguinal adi-
pocytes [5]. Starting from the eighth day of the experi-
ment, the females examined ate more than the control 
animals (average about 2 grams per day). In this paper, 
we observe that long-term treatment of females with 
progesterone leads to a significant increase in NPY and 
a decrease in CART mRNA levels in the hypothalamus 
respectively. These changes could explain the observed 
increase in food intake in the females. Our results are 
inconsistent with the data presented by Trujillo et al. 
[6]. They demonstrated that, despite hyperphagia, NPY 
mRNA level in hypothalamus was unchanged in pseu-
dopregnant rats [6]. However, it should be emphasised 
that the serum progesterone concentration of these 
animals was three times lower compared to our results 
and reached the value characteristic for the control rats 
in our experiment. 
It seems that the level of circulating hormone may be 
a decisive factor for progesterone’s actions in the tissue. 
Different strains of rats used in these experiments could 
also be the reason for different results. The regulation of 
the expression of these neuropeptides during gestation 
is still controversial. Most of the results indicate that in 
the hypothalamus of pregnant rats NPY gene expres-
sion is up-regulated [6, 26, 27]. Little is known about the 
influence of steroid hormones on CART gene expres-
sion. Studies in monkeys showed that CART protein 
level in midbrain CART neurons was unchanged by 
progesterone administration [28]. 
To the best of our knowledge, we showed for the first 
time that CART gene expression is down-regulated by 
elevated concentration of circulating progesterone in 
female rats. It is also noteworthy that the POMC mRNA 
level (another anorexigenic peptide) is lower in pregnant 
rats [6]. However, other results indicate that the level of 
POMC mRNA does not change during pregnancy [27].
The mechanism leading to changes in neuropeptide 
genes expression is not clear. The sequence analysis of 
the promoter regions of NPY and CART genes predicted 
one and two PR binding site respectively (see Material 
and Methods). Thus, we consider that progesterone 
may directly regulate the NPY and CART genes expres-
sion. There is also a possibility that progesterone may 
act indirectly, affecting the expression of genes involved 
in regulation of neuropeptides levels. The most im-
portant factor regulating hypothalamic neuropeptides 
mRNA abundance is circulating leptin [29, 30]. We have 
shown previously that the concentration of plasma 
leptin in females treated with progesterone does not 
change despite an increase in leptin gene expression in 
inguinal adipose tissue [5]. We also observed no changes 
in serum concentrations of the other adipokines (such as 
adiponectin) or steroid hormones (cortisol and aldoster-
one) in progesterone treated animals (data not shown). 
It is therefore likely that the observed changes are 
a direct effect of progesterone’s action, especially that 
progesterone can enter the hypothalamus. Another 
example of the action of progesterone in the hypo-
thalamus is change in the progesterone receptor gene 
expression of progesterone treated females. Our data 
indicates for the first time that PR mRNA level in hypo-
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thalamus of females was down-regulated by elevated 
concentration of circulating progesterone, as it is in the 
classic progesterone target tissues [31]. 
Our results indicated that in males the elevated 
concentration of circulating progesterone had no ef-
fects on neuropeptides or progesterone receptor mRNA 
level in hypothalamus. Too low serum concentration of 
progesterone could contribute to the lack of changes in 
gene expression. Despite the several-fold increase of 
circulating progesterone concentration in progesterone-
treated males, the total concentration barely reached 
the value observed in non-treated control females (Ta-
ble I). Consequently, the serum progesterone level in 
progesterone-treated males was approximately 2.5-fold 
lower than in progesterone-treated females. 
No changes in the gene expression of neuropeptides 
in the hypothalamus of males suggest that despite the 
presence of progesterone receptor the serum concentra-
tion of this hormone may be a very important factor. It 
is worth noting that we likewise found no changes in 
gene expression in other organs of males treated with 
progesterone, unlike with females [4]. 
Conclusions
Our study demonstrates that chronic increase in circulat-
ing progesterone concentration in females is associated 
with up-regulation of NPY and down-regulation of 
CART genes expression in hypothalamus. These changes 
can lead to stimulation of appetite and could explain 
the observed increase in food intake, body, and adipose 
tissue mass in females. In males, elevated blood proges-
terone concentration had no effect on body and adipose 
tissue mass, and on the neuropeptide genes expression 
in hypothalamus. We also discovered that chronically 
elevated concentration of progesterone decreases PR 
gene expression in hypothalamus of females, similarly 
as observed in other tissues. It seems that the responsive-
ness of hypothalamus to progesterone may be depend-
ent upon the serum concentration of this hormone.
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